<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04386200</url>
  </required_header>
  <id_info>
    <org_study_id>VITA02</org_study_id>
    <nct_id>NCT04386200</nct_id>
  </id_info>
  <brief_title>Web-based Approach in Nutrition and Diabetes</brief_title>
  <official_title>Educational Approach, Clinical Nutrition and Type 2 Diabetes: Traditional Strategies and Innovative Technologies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi 'G. d'Annunzio' Chieti e Pescara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi 'G. d'Annunzio' Chieti e Pescara</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to test web-based strategies, in overweight or obese participants at risk or
      affected by Type 2 Diabetes Mellitus , to promote adherence over time to a healthy lifestyle
      and nutritional medical therapy (TMN). The study population includes 40 subjects, randomly
      allocated to web group (therapeutic reinforcement through web-based strategies) or
      traditional group (traditional educational approach). Anthropometric and clinical parameters
      will be collected, as well as scores of validated questionnaires will be administered up to
      12 months from the enrollment.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 13, 2019</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Body Weight</measure>
    <time_frame>Baseline, month 3, month 6, month 9 and month12</time_frame>
    <description>Assessment of body weight (in kilograms) at baseline and after 3, 6, 9 and 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in BMI</measure>
    <time_frame>Baseline, month 3, month 6, month 9 and month12</time_frame>
    <description>Assessment of BMI (kg/m^2) at baseline and after 3, 6, 9 and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in body circumferences</measure>
    <time_frame>Baseline, month 3, month 6, month 9 and month12</time_frame>
    <description>Assessment of body circumferences (in centimeters) at baseline and after 3, 6, 9 and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Systolic and Diastolic blood pressure</measure>
    <time_frame>Baseline, month 3, month 6, month 9 and month12</time_frame>
    <description>Assessment of Systolic and Diastolic blood pressure (mm hg) at baseline and after 3, 6, 9 and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in fasting blood glucose</measure>
    <time_frame>Baseline, month 3, month 6, month 9 and month12</time_frame>
    <description>Assessment of fasting blood glucose (mg/dl) at baseline and after 3, 6, 9 and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in HbA1C</measure>
    <time_frame>Baseline, month 3, month 6, month 9 and month12</time_frame>
    <description>Assessment of HbA1C at baseline and after 3, 6, 9 and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Dietary habits estimated by PREvencion con DIetaMEDiterranea questionnaire (PREDIMED questionnaire)</measure>
    <time_frame>Baseline, month 3, month 6, month 9 and month12</time_frame>
    <description>Assessment of Dietary habits at baseline and after 3, 6, 9 and 12 months. Changes in dietary habits will be estimated using a 14-item PREDIMED questionnaire which is a questionnaire to assess the adherence to the Mediterranean diet, 0 being the minimum total score and 14 the maximum total score. Higher values represent a higher adherence to the Mediterranean diet.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in physical activity level estimated by the International Physical Activity Questionnaire (IPAQ) - short form</measure>
    <time_frame>Baseline, month 3, month 6, month 9 and month12</time_frame>
    <description>Assessment of physical activity level at baseline and after 3, 6, 9 and 12 months. Changes in the level of physical exercise will be estimated by the International Physical Activity Questionnaire (IPAQ-short form) which is a questionnaire to assess the level of physical activity. Patients are asked to measure the average amount of time spent in sedentary behaviours and different intensity levels of physical activity. The questionnaire obtains three different intensity levels of physical activity: low, moderate and high.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Quality of life by 36-item short form health survey (SF-36)</measure>
    <time_frame>Baseline, month 3, month 6, month 9 and month12</time_frame>
    <description>Assessment of Quality of life by SF-36 at baseline and after 3, 6, 9 and 12 months. The 36-Item Short Form Health Survey (SF-36) is a self-report generic quality of life measure. The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) with scores ranging from 0 to 100. Higher scores indicate greater self-reported quality of life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Overweight and Obesity</condition>
  <condition>Nutritional and Metabolic Diseases</condition>
  <arm_group>
    <arm_group_label>WEB GROUP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traditional approach integrated with web-based technologies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRADITIONAL GROUP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Traditional educational approach</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>web-based thecnologies</intervention_name>
    <description>Integration of &quot;traditional&quot; face-to-face educational approach with web-based technologies.</description>
    <arm_group_label>WEB GROUP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>traditional approach</intervention_name>
    <description>&quot;traditional&quot; face-to-face educational approach</description>
    <arm_group_label>TRADITIONAL GROUP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight or obesity (BMI ≥25 kg/m2)

          -  Participants with or at risk of Type 2 Diabetes Mellitus

          -  Skills in the use web-based technologies and internet accessibility

        Exclusion Criteria:

          -  Conditions that could interfere with the execution and completion of the project or
             failure adherence to the protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital &quot;SS Annunziata&quot;</name>
      <address>
        <city>Chieti</city>
        <zip>66100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 5, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2020</study_first_posted>
  <last_update_submitted>May 13, 2020</last_update_submitted>
  <last_update_submitted_qc>May 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi 'G. d'Annunzio' Chieti e Pescara</investigator_affiliation>
    <investigator_full_name>Ester Vitacolonna</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Web technologies</keyword>
  <keyword>Nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

